Substance Use Disorder Statistics in New York

Substance Use Disorder (SUD) represents a significant public health challenge in New York, with prevalence rates that exceed the national average. According to the National Survey on Drug Use and Health, New York's 12-month SUD prevalence rate for individuals 12 and older is approximately 7.3%^[3], compared to the national average of about 8.7%^[3], though other state-level reports indicate New York's overall prevalence is higher^[3]. This places the state between the 15th and 20th highest for SUD prevalence in the U.S.^[3]. The condition has far-reaching social and economic consequences, contributing to chronic health issues, reduced workforce productivity, and a higher risk of overdose deaths^[5]. For context, an estimated 46.3 million Americans were living with an SUD in 2021^[6], with the national past-year prevalence reaching 16.8% in 2024 for those aged 12 or older^[7].

Substance use disorder does not affect all New Yorkers equally. Significant disparities exist based on age, geography, socioeconomic status, and co-occurring conditions. For instance, younger adults tend to report higher rates of drug use disorder, while alcohol use disorder is more common among those over 26^[2]. In New York City, an estimated 12.5% of individuals aged 15-24 experience SUD^[3]. Co-occurring disorders are also common, with anxiety being the most prevalent mental health condition at 18%^[9], followed by major depressive disorder at 11%^[9] and PTSD at 5%^[9]. Furthermore, problem gambling affects 10% of youth, and about a quarter of them also report substance abuse problems^[1].

The most severe consequence of substance use disorder is fatal overdose, and the data reveals profound racial disparities in these outcomes. Nationally, over 110,000 drug overdose deaths were recorded in 2022, driven largely by synthetic opioids^[11]. In New York, Black residents with SUD face overdose-related mortality rates that are approximately 25% higher than their White counterparts^[2]. These statistics underscore the urgent need for equitable access to harm reduction services, treatment, and culturally competent care to address the systemic factors contributing to these unequal outcomes.

Despite the high prevalence of SUD, a vast majority of affected individuals do not receive care. Nationally, over 90% of those with an SUD have not sought or received treatment^[6]. Systemic issues like stigma, insufficient funding, and regulatory hurdles hinder access statewide^[3]. The high reliance on Medicaid for SUD treatment highlights both the program's importance and a broader socioeconomic challenge^[8]. To address this, Governor Hochul announced a $1 billion multi-year plan in 2022 to overhaul the state's mental health care services^[14].

Access to care is heavily influenced by where a person lives. Experts warn that the unequal distribution of treatment facilities contributes to health outcome disparities^[8]. High-poverty areas like the Bronx often have fewer mental health providers per capita, creating treatment deserts^[15]. While New York City has a relatively high density of facilities at 15 per 100,000 people^[16], some boroughs have as few as three specialized centers per 100,000 residents^[2]. Statewide, there are an estimated 12 specialized facilities per 100,000 residents^[8].

The landscape of substance use and mental health in New York is dynamic. The COVID-19 pandemic exacerbated the crisis by increasing isolation and disrupting services, leading to a spike in substance misuse^[17]. However, recent data shows some positive trends, including a decrease in the opioid overdose death rate from 15.2 per 100,000 in 2020 to 12.8 in 2022^[8]. In contrast, the state's age-adjusted suicide rate has increased by nearly 35% over the past two decades, reaching 8.5 per 100,000 in 2022^[18]. Public health initiatives have shown success in areas like reducing binge drinking^[19] and setting goals for lowering drug-related hospitalizations^[20]. Despite challenges, New York was ranked among the top states for mental health outcomes in 2024^[21].